Today’s Top Three in Pharma 022009 posted on February 20, 2009Genentech's Raptiva: Trouble - The FDA said today that patients taking the Genentech drug Raptiva are at risk of developing a potentially fatal condition known as PML, or progressive multifocal …Continue Reading about Today’s Top Three in Pharma 022009 →